Articles
EPR Academy, Part 2 of 6: The EPR Process – From Request to Reexamination Certificate
December 5, 2025
IP Updates
Federal Circuit IP Blog
Federal Circuit Affirms § 102(b) Invalidity; Source Code Commands Are Not Hearsay
May 14, 2026
Never miss an Insight.
Sign upWebinar
What’s Working at the PTAB Now: Strategies for Petitioners and Patent Owners What’s Working at the PTAB Now: Strategies for Petitioners and Patent Owners
March 4, 2026
Webinar
Webinar
Protect Your Innovations: Recent Patent Case Law in the Life Sciences Protect Your Innovations: Recent Patent Case Law in the Life Sciences
February 11, 2026
Webinar
Webinar
Recent Pharmaceutical, Chemical, and Biotech Case Law on Infringement Under the Doctrine of Equivalents Recent Pharmaceutical, Chemical, and Biotech Case Law on Infringement Under the Doctrine of Equivalents
February 18, 2025
Webinar
Webinar
Patenting Pharmaceutical Drug Formulations: Withstanding Litigation and PTAB Challenges Patenting Pharmaceutical Drug Formulations: Withstanding Litigation and PTAB Challenges
January 9, 2025
Webinar
Webinar
Recent Court Decisions in the Life Sciences Recent Court Decisions in the Life Sciences
May 22, 2024
Webinar
Webinar
Recent IPR and District Court Litigation in the Life Sciences Recent IPR and District Court Litigation in the Life Sciences
July 12, 2023
Webinar
Webinar
Recent Patent Case Law in the Pharmaceutical, Chemical, and Biotech Fields Recent Patent Case Law in the Pharmaceutical, Chemical, and Biotech Fields
September 21, 2022
Webinar
Webinar
Patent Case Law Developments for Pharmaceutical, Chemical, and Biotech Companies and Practitioners Patent Case Law Developments for Pharmaceutical, Chemical, and Biotech Companies and Practitioners
March 8, 2022
Webinar
Webinar
Recent Patent Case Law in the Pharmaceutical, Chemical, and Biotech Fields Recent Patent Case Law in the Pharmaceutical, Chemical, and Biotech Fields
September 28, 2021
Webinar
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.